Prescription medicines with potential for foetal harm: dispensing before and during pregnancy in New Zealand, 2005

Prescription medicines with potential for foetal harm: dispensing before and during pregnancy in New Zealand, 2005–2015

Published:2020-04-04 Issue:6 Volume:76 Page:887-896
ISSN:0031-6970
Container-title:European Journal of Clinical Pharmacology
language:en
Short-container-title:Eur J Clin Pharmacol

Author:

Donald Sarah^ORCID,Sharples Katrina^ORCID,Barson David,Horsburgh Simon^ORCID,Parkin Lianne^ORCID

Funder

Health Research Council of New Zealand

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00228-020-02868-2.pdf

Reference32 articles.

1. Lo WY, Friedman JM (2002) Teratogenicity of recently introduced medications in human pregnancy. Obstet Gynecol 100(3):465–473. https://doi.org/10.1016/S0029-7844(02)02122-1

2. Adam MP, Polifka JE, Friedman JM (2011) Evolving knowledge of the teratogenicity of medications in human pregnancy. American journal of medical genetics part C: seminars in medical. Genetics 157(3):175–182. https://doi.org/10.1002/ajmg.c.30313

3. Therapeutic Goods Administration (2011) Australian categorisation system for prescribing medicines in pregnancy. Department of Health, Australian Government. https://www.tga.gov.au/australian-categorisation-system-prescribing-medicines-pregnancy. Accessed 16/03/2019

4. Kennedy D (2014) Classifying drugs in pregnancy. Aust Prescr 37:112–141. https://doi.org/10.18773/austprescr.2014.018

5. Doering PL, Boothby LA, Cheok M (2002) Review of pregnancy labeling of prescription drugs: is the current system adequate to inform of risks? Am J Obstet Gynecol 187(2):333–339. https://doi.org/10.1067/mob.2002.125740

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trends in harmful drug exposure during pregnancy in France between 2013 and 2019: A nationwide cohort study;PLOS ONE;2024-01-10

2. Management of pregnancy-related hypertensive disorders in patients infected with SARS CoV-2: pharmacological and clinical issues;European Heart Journal - Cardiovascular Pharmacotherapy;2020-09-10